Boca Raton, Florida — (Business Wire) — Massive Bio has recently received certification from the French National Commission on Information Technology and Civil Liberties (CNIL), confirming its full compliance with the European Union's General Data Protection Regulation (GDPR) and France's medical data protection laws. This certification enables Massive Bio to securely process medical records of French patients through its cloud platform, significantly enhancing the company's credibility and capabilities in data protection. According to CNIL, Massive Bio’s cloud platform has undergone rigorous testing and review to ensure the safety and compliance of data handling processes. This certification not only builds trust in the French market but also paves the way for further expansion. CNIL’s endorsement indicates that Massive Bio meets high standards in data protection and privacy management, effectively safeguarding the sensitive information of patients. Massive Bio’s CEO stated, “Achieving CNIL certification is a significant milestone in our European growth strategy. It is a testament to our technological capabilities and commitment to data security. We remain dedicated to providing the highest standards of data processing services globally.” Since the GDPR came into effect in 2018, many technology companies have been actively working to align with these regulations. Massive Bio’s certification solidifies its position as a leader in medical data processing. As data protection laws become increasingly stringent, this certification will undoubtedly support the company’s expansion in France and other European countries. Moreover, the certification marks the addition of a strong new member to the FrenchTech community, injecting fresh energy into the medical technology market in France and Europe. Massive Bio is poised to collaborate with more French healthcare institutions, offering more efficient and secure medical data processing services. To date, Massive Bio has established partnerships with healthcare providers in several countries, demonstrating its significant potential in the global market. With the opening of the French market, the company is expected to experience substantial growth over the next few years.